Clinical Trial Update: Use of Flaxseed(Alpha Linolenic Acid) Powder in Morbidly Obese Patients With Systemic Inflammation [Phase 2]

View source ↗

Summary

Phase 2 clinical trial investigating flaxseed powder containing alpha-linolenic acid in morbidly obese patients with systemic inflammation. Sponsored by the Uni…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atherosclerosis
• Morbid Obesity

Drugs mentioned

• Flaxseed Powder (Alpha-Linolenic Acid) (alpha-linolenic acid powder)

Snippet

Sponsor: University of Sao Paulo | Conditions: Morbid Obesity, Atherosclerosis | Phase 2 | Status: UNKNOWN